Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.830
0.00 (0.00%)
At close: May 11, 2026, 4:00 PM EDT
1.810
-0.020 (-1.09%)
Pre-market: May 12, 2026, 8:45 AM EDT
Compass Therapeutics Employees
Compass Therapeutics had 39 employees as of December 31, 2025. The number of employees increased by 4 or 11.43% compared to the previous year.
Employees
39
Change (1Y)
4
Growth (1Y)
11.43%
Revenue / Employee
n/a
Profits / Employee
-$1,748,026
Market Cap
329.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 4 | 11.43% |
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Abeona Therapeutics | 226 |
| Neumora Therapeutics | 96 |
| Silence Therapeutics | 88 |
| Lineage Cell Therapeutics | 77 |
| Rezolute | 75 |
| Armata Pharmaceuticals | 60 |
| Immuneering | 53 |
CMPX News
- 1 hour ago - Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewsWire
- 7 days ago - Compass Therapeutics reports Q1 EPS (10c), consensus (10c) - TheFly
- 7 days ago - Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 14 days ago - Compass Therapeutics price target lowered to $7 from $13 at Canaccord - TheFly
- 14 days ago - Compass Therapeutics downgraded to Market Perform from Outperform at Raymond James - TheFly
- 14 days ago - Compass Therapeutics price target lowered to $6 from $12 at Stifel - TheFly
- 14 days ago - Compass Therapeutics selloff ‘an over-reaction,’ says Jefferies - TheFly
- 14 days ago - Leerink says Compass data supports path forward for tovecimig in 2L BTC - TheFly